Price $20.67 |
Market Cap
1.48B
|
Sector Health Care |
Div. Growth
-75.00%
|
|
P/E
12.1
|
P/B
1.51
|
P/S
0.15
|
Dividend %
0.10%
|
|
P/CF
39.4
|
P/FCF
9.0
|
Op. Cash Flow
288.4K
|
FCF
2.1
|
|
Op. Margin
2.60%
|
Net Margin
1.20%
|
ROE
12.80%
|
ROI
14.50%
|
|
ROA
2.40%
|
EPS Growth
-48.30%
|
Current Ratio
1.7
|
Debt/Equity
101.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Societal CDMO Inc (SCTL) | $1.35 | - | - | 120.9M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.21 | - | - | 54.1M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.38 | - | - | 10.35B | Strong Buy |
| Avalo Therapeutics Inc (AVTX) | $4.00 | - | - | 47.6M | Strong Buy |
| Clover Health Investments Corp (CLOV) | $1.25 | - | - | 443.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
